Bausch Health Companies Inc.
BHC.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.87% | 10.92% | 10.23% | 10.10% | 7.95% |
| Total Other Revenue | 13.83% | 9.68% | 7.61% | 2.13% | -5.05% |
| Total Revenue | 9.91% | 10.91% | 10.20% | 10.01% | 7.79% |
| Cost of Revenue | 8.71% | 10.14% | 8.92% | 9.27% | 8.25% |
| Gross Profit | 10.41% | 11.23% | 10.74% | 10.32% | 7.60% |
| SG&A Expenses | 13.07% | 15.42% | 12.78% | 9.77% | 12.20% |
| Depreciation & Amortization | 0.00% | -0.72% | -5.76% | -8.49% | -11.36% |
| Other Operating Expenses | 200.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Operating Expenses | 8.63% | 9.83% | 7.83% | 6.65% | 6.69% |
| Operating Income | 15.60% | 15.88% | 21.85% | 27.45% | 12.99% |
| Income Before Tax | 142.82% | 93.38% | -1,516.00% | -76.50% | -202.33% |
| Income Tax Expenses | 8.14% | -28.21% | -28.50% | -9.30% | 166.27% |
| Earnings from Continuing Operations | 88.22% | 77.72% | -168.25% | -34.93% | -188.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 36.84% | 254.55% | 1,100.00% | 1,300.00% | 246.15% |
| Net Income | 92.23% | 81.52% | -153.23% | -27.45% | -163.11% |
| EBIT | 15.60% | 15.88% | 21.85% | 27.45% | 12.99% |
| EBITDA | 8.84% | 8.39% | 9.04% | 9.93% | 1.95% |
| EPS Basic | 92.13% | 81.56% | -152.65% | -26.94% | -162.00% |
| Normalized Basic EPS | 70.25% | 65.19% | 313.61% | 468.15% | 620.48% |
| EPS Diluted | 92.14% | 81.58% | -151.03% | -26.81% | -161.37% |
| Normalized Diluted EPS | 70.24% | 65.17% | 314.11% | 468.06% | 620.50% |
| Average Basic Shares Outstanding | 1.87% | 0.09% | 0.08% | 0.05% | -0.02% |
| Average Diluted Shares Outstanding | 1.87% | 0.09% | 0.02% | 0.15% | 0.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
